Sudarshan Pharma Industries Limited

BSE:543828 Stock Report

Market Cap: ₹1.6b

Sudarshan Pharma Industries Management

Management criteria checks 2/4

Sudarshan Pharma Industries' CEO is Hemal Mehta, appointed in Nov 2018, has a tenure of 5.5 years. total yearly compensation is ₹4.50M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 28.51% of the company’s shares, worth ₹454.59M. The average tenure of the management team and the board of directors is 5.8 years and 1.8 years respectively.

Key information

Hemal Mehta

Chief executive officer

₹4.5m

Total compensation

CEO salary percentage100.0%
CEO tenure5.5yrs
CEO ownership28.5%
Management average tenure5.8yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Hemal Mehta's remuneration changed compared to Sudarshan Pharma Industries's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023₹5m₹5m

₹70m

Mar 31 2022₹4m₹4m

₹52m

Mar 31 2021₹1m₹1m

₹27m

Mar 31 2020₹500k₹500k

₹13m

Compensation vs Market: Hemal's total compensation ($USD54.02K) is above average for companies of similar size in the Indian market ($USD39.52K).

Compensation vs Earnings: Hemal's compensation has been consistent with company performance over the past year.


CEO

Hemal Mehta (46 yo)

5.5yrs

Tenure

₹4,500,000

Compensation

Mr. Hemal Vasantrai Mehta serves as a Managing Director at Sudarshan Pharma Industries Limited since November 8, 2018 and its Executive Director since January 16, 2015. He serves as the Chairman at Sudarsh...


Leadership Team

NamePositionTenureCompensationOwnership
Hemal Mehta
Chairman & MD5.5yrs₹4.50m28.51%
₹ 454.6m
Sachin Mehta
CFO, Joint MD & Director5.8yrs₹4.50m28.88%
₹ 460.4m
Shrishti Mayekar
Head of Sales & Marketingno datano datano data
Indraraj Neogi
Head of Sales & Marketing of Pharma Division6.8yrsno datano data
Bhavesh Kankia
Supply Chain Purchase Headno datano datano data
Geeta Asare
Supply Chain Logistics Headno datano datano data
Shrinivas Patil
Export Headno datano datano data
Vinay Singh
Independent Head of Pharma business in Manufacturing & Strategic Marketingno datano data0.25%
₹ 4.0m

5.8yrs

Average Tenure

43yo

Average Age

Experienced Management: 543828's management team is seasoned and experienced (5.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Hemal Mehta
Chairman & MD9.3yrs₹4.50m28.51%
₹ 454.6m
Sachin Mehta
CFO, Joint MD & Director15.8yrs₹4.50m28.88%
₹ 460.4m
Rushabh Patil
Additional Independent Directorless than a yearno datano data
Umesh Luthra
Independent Director2.2yrsno datano data
Jaya Singhania
Independent Director1.4yrsno datano data
Anil Ghogare
Additional Non-Executive Directorless than a yearno datano data

1.8yrs

Average Tenure

40yo

Average Age

Experienced Board: 543828's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.